Chloé E. Atreya

6.0k total citations · 2 hit papers
96 papers, 2.5k citations indexed

About

Chloé E. Atreya is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Chloé E. Atreya has authored 96 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Oncology, 29 papers in Molecular Biology and 20 papers in Pathology and Forensic Medicine. Recurrent topics in Chloé E. Atreya's work include Colorectal Cancer Treatments and Studies (35 papers), Genetic factors in colorectal cancer (18 papers) and Cancer survivorship and care (15 papers). Chloé E. Atreya is often cited by papers focused on Colorectal Cancer Treatments and Studies (35 papers), Genetic factors in colorectal cancer (18 papers) and Cancer survivorship and care (15 papers). Chloé E. Atreya collaborates with scholars based in United States, Japan and South Korea. Chloé E. Atreya's co-authors include Scott Kopetz, Alan P. Venook, Ryan B. Corcoran, Katherine Van Loon, Karen S. Anderson, Johanna C. Bendell, Monica Motwani, Robin Kate Kelley, Keith Orford and Wells A. Messersmith and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Chloé E. Atreya

94 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600–Mutant Colorectal Cancer

2015 382 citations Ryan B. Corcoran, Chloé E. Atreya et al. profile →
Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology–ASCO Guideline

2023 82 citations Chloé E. Atreya et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chloé E. Atreya United States	27	1.7k	807	726	711	577	96	2.5k
Howard J. Lim Canada	28	1.1k 0.6×	610 0.8×	344 0.5×	438 0.6×	593 1.0×	184	2.3k
Alessandro Passardi Italy	23	1.5k 0.9×	497 0.6×	308 0.4×	681 1.0×	488 0.8×	138	2.2k
Alexander Stein Germany	28	1.9k 1.1×	542 0.7×	422 0.6×	351 0.5×	972 1.7×	165	3.0k
Christina Wu United States	29	2.2k 1.3×	561 0.7×	537 0.7×	549 0.8×	725 1.3×	168	3.1k
Aung Ko Win Australia	31	1.8k 1.0×	707 0.9×	1.6k 2.2×	731 1.0×	500 0.9×	113	3.2k
Marcia Cruz‐Correa United States	28	1.0k 0.6×	974 1.2×	713 1.0×	439 0.6×	595 1.0×	124	3.0k
Erika Cecchin Italy	27	1.5k 0.9×	1.2k 1.5×	240 0.3×	363 0.5×	406 0.7×	125	2.6k
Yuanyuan Zhao China	29	1.9k 1.1×	558 0.7×	257 0.4×	533 0.7×	1.1k 1.9×	162	3.0k
Adnan Ghafoor United States	2	1.5k 0.8×	891 1.1×	297 0.4×	512 0.7×	907 1.6×	3	3.2k
Anne M. Noonan United States	27	1.3k 0.7×	561 0.7×	189 0.3×	360 0.5×	396 0.7×	117	2.1k

Countries citing papers authored by Chloé E. Atreya

Since Specialization

Citations

This map shows the geographic impact of Chloé E. Atreya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé E. Atreya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé E. Atreya more than expected).

Fields of papers citing papers by Chloé E. Atreya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé E. Atreya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé E. Atreya. The network helps show where Chloé E. Atreya may publish in the future.

Co-authorship network of co-authors of Chloé E. Atreya

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé E. Atreya. A scholar is included among the top collaborators of Chloé E. Atreya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé E. Atreya. Chloé E. Atreya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kyaw, Than S., C. Anders Olson, Cecilia Noecker, et al.. (2025). Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity. Science Translational Medicine. 17(794). eadq8870–eadq8870. 2 indexed citations

Parikh, Aparna R., Thereasa A. Rich, Kristin S. Price, et al.. (2024). Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment. Clinical Cancer Research. 30(14). 2964–2973. 10 indexed citations

Wright, Francis, A. Jo Chien, Jasmine Wong, et al.. (2024). Synchronous or metachronous breast and colorectal cancers in younger-than-average-age patients: a case series. The Oncologist. 29(9). e1159–e1168. 1 indexed citations

Tolstykh, Irina, Erin L. Van Blarigan, Katherine Van Loon, et al.. (2024). Association between gastrointestinal symptoms and specialty care utilization among colon cancer survivors: a cohort study. International Journal of Colorectal Disease. 39(1). 130–130.

Kyaw, Than S., Vaibhav Upadhyay, Irina Tolstykh, et al.. (2023). Variety of Fruit and Vegetables and Alcohol Intake are Associated with Gut Microbial Species and Gene Abundance in Colorectal Cancer Survivors. American Journal of Clinical Nutrition. 118(3). 518–529. 7 indexed citations

Tolstykh, Irina, Katherine Van Loon, Angela Laffan, et al.. (2022). Association between adherence to the American Cancer Society Nutrition and Physical Activity Guidelines and stool frequency among colon cancer survivors: a cohort study. Journal of Cancer Survivorship. 17(3). 836–847. 8 indexed citations

Bischoff, Kara, et al.. (2020). Embedded palliative care for patients with metastatic colorectal cancer: a mixed-methods pilot study. Supportive Care in Cancer. 28(12). 5995–6010. 8 indexed citations

Thompson‐Lastad, Ariana, et al.. (2019). Improving Access to Integrative Oncology Through Group Medical Visits: A Pilot Implementation Project. The Journal of Alternative and Complementary Medicine. 25(7). 733–739. 11 indexed citations

Dhruva, Anand, Chloé E. Atreya, & Maria T. Chao. (2018). Applying New Models of Care to Meet Patient Needs in Integrative Oncology. The Journal of Alternative and Complementary Medicine. 24(9-10). 1010–1011. 6 indexed citations

10.

Atreya, Chloé E., Ai Kubo, Hala T. Borno, et al.. (2018). Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS ONE. 13(7). e0199423–e0199423. 31 indexed citations

11.

Paciorek, Alan, Li Zhang, Erin L. Van Blarigan, et al.. (2018). Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. Journal of Gastrointestinal Cancer. 50(4). 769–779. 20 indexed citations

12.

Strickler, John H., Jonathan M. Loree, Leanne G. Ahronian, et al.. (2017). Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. Cancer Discovery. 8(2). 164–173. 196 indexed citations

13.

Rajaram, Satwik, John D. Gordan, Agnieszka K. Witkiewicz, et al.. (2017). Sampling strategies to capture single-cell heterogeneity. Nature Methods. 14(10). 967–970. 24 indexed citations

14.

Ritchie, Christine S., et al.. (2017). Symptom Burden in Patients Initiating Treatment for Metastatic Colorectal Cancer (SA527B). Journal of Pain and Symptom Management. 53(2). 408–408. 1 indexed citations

15.

Parikh, Aparna R., Chloé E. Atreya, W. Michael Korn, & Alan P. Venook. (2016). Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer. Journal of the National Comprehensive Cancer Network. 15(1). 3–8. 23 indexed citations

16.

Corcoran, Ryan B., Thierry André, Takayuki Yoshino, et al.. (2016). Efficacy and circulating tumor DNA (ctDNA) analysis of the BRAF inhibitor dabrafenib (D), MEK inhibitor trametinib (T), and anti-EGFR antibody panitumumab (P) in patients (pts) with BRAF V600E–mutated (BRAFm) metastatic colorectal cancer (mCRC). Annals of Oncology. 27. vi150–vi150. 36 indexed citations

17.

Strosberg, Jonathan, Mauro Cives, Justin H. Hwang, et al.. (2016). A phase II study of axitinib in advanced neuroendocrine tumors. Endocrine Related Cancer. 23(5). 411–418. 47 indexed citations

18.

Zill, Oliver A., Claire Greene, Dragan Sebisanovic, et al.. (2015). Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. Cancer Discovery. 5(10). 1040–1048. 202 indexed citations

19.

Warren, Robert S., Chloé E. Atreya, Donna Niedzwiecki, et al.. (2013). Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803. Clinical Cancer Research. 19(20). 5777–5787. 32 indexed citations

20.

Atreya, Chloé E. & Karen S. Anderson. (2004). Kinetic Characterization of Bifunctional Thymidylate Synthase-Dihydrofolate Reductase (TS-DHFR) from Cryptosporidium hominis. Journal of Biological Chemistry. 279(18). 18314–18322. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact